Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents. [electronic resource]
Producer: 20120227Description: 1119-28 p. digitalISSN:- 1876-7605
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Aspirin -- therapeutic use
- Belgium
- Confidence Intervals
- Coronary Restenosis -- drug therapy
- Drug-Eluting Stents -- adverse effects
- Female
- France
- Humans
- Immunosuppressive Agents -- adverse effects
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Paclitaxel -- therapeutic use
- Platelet Aggregation Inhibitors -- adverse effects
- Risk Assessment
- Sirolimus -- adverse effects
- Thienopyridines -- adverse effects
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.